Greater than 4 in ten older People take 5 or extra prescription medicines, and this research suggests weight problems might account for tens of millions of these circumstances. Researchers say decreasing weight problems may assist decrease medicine burden in later life.
Examine: Contribution of Weight problems to Polypharmacy in U.S. Older Adults. Picture credit score: Kotcha Ok/Shutterstock.com
A latest Journal of Basic Inside Drugs research examined whether or not weight problems was related to polypharmacy utilizing a nationally consultant pattern of U.S. older adults.
Weight problems provides to medicine burden in later life
Polypharmacy, broadly outlined because the concurrent use of 5 or extra medicines by a person, is very prevalent amongst older adults. This widespread use of a number of medicines is linked to quite a lot of adverse outcomes, equivalent to opposed drug occasions, elevated therapy burden, and diminished high quality of life. Managing quite a few medicines can enhance the probability of complicated drug interactions, medicine nonadherence, and a better threat of dangerous unintended effects. These challenges can considerably have an effect on the well being and day by day functioning of older individuals.
Weight problems performs a big position within the improvement of continual well being circumstances, together with diabetes, hypertension, and heart problems, that often require ongoing pharmacologic administration. Consequently, people with weight problems are at an elevated threat for polypharmacy in comparison with these with out weight problems. Regardless of this affiliation, the precise contribution of weight problems to polypharmacy prevalence amongst older adults stays unclear and warrants additional investigation.
Nationwide survey examined weight problems and medicine use
The present cross-sectional evaluation utilized information from the 2021–2023 Nationwide Well being and Vitamin Examination Survey (NHANES). Adults aged over 65 years with physique mass index (BMI) ≥ 18.5 kg/m² had been included. Any contributors with lacking information on BMI or medicine use had been excluded.
Weight problems, outlined by BMI (≥ 30 kg/m²) or waist circumference (≥ 102 cm in males, ≥ 88 cm in girls), and weight problems class (class 1: BMI 30–<35 kg/m²; class 2–4: BMI ≥ 35 kg/m²) served as unbiased variables. Polypharmacy, outlined as self-reported use of 5 or extra prescription medicines, was the dependent variable.
Teams with and with out weight problems had been in contrast on demographic and medical traits utilizing χ² and t-tests. Logistic regression estimated the adjusted relative threat of polypharmacy amongst BMI-defined overweight people, adjusting for key covariates. The inhabitants attributable fraction (PAF) of polypharmacy as a result of weight problems was calculated utilizing the adjusted relative threat and weight problems prevalence, with extra PAF values decided for weight problems class and waist circumference.
Weight problems was linked to increased polypharmacy prevalence
The research included 1,944 contributors, representing an estimated 53.2 million U.S. older adults, with a median age of 72.7 years. Simply over half had been girls, and the pattern mirrored the racial and ethnic range of the older U.S. inhabitants.
Polypharmacy was widespread, affecting 41.8% of contributors, equal to roughly 22 million older adults nationwide. Weight problems was additionally widespread: practically 39% of contributors had weight problems primarily based on BMI, whereas greater than 70% met the definition primarily based on waist circumference.
Older adults with BMI-defined weight problems had been significantly extra prone to expertise polypharmacy than these with out weight problems, with prevalence charges of 51.1% and 35.9%, respectively. Based mostly on these findings, the researchers estimated that round 3.3 million circumstances of polypharmacy, or 14.8% of all circumstances amongst older adults, had been attributable to BMI-defined weight problems.
The estimated contribution various in response to the definition and severity of weight problems. Class I weight problems accounted for 4.9% of polypharmacy circumstances, whereas class II-IV weight problems accounted for 9.7%. When weight problems was outlined utilizing waist circumference, the estimated attributable fraction elevated to 24.8%, suggesting that central weight problems might have an excellent stronger affiliation with polypharmacy than BMI alone.
The authors highlighted a number of limitations of the present research, together with potential errors in self-reported medicine information and the exclusion of long-term care residents, which scale back generalizability. Unmeasured confounders, equivalent to socioeconomic standing or healthcare entry, would possibly affect outcomes. Subgroup variations in PAF weren’t explored.
The cross-sectional design additional limits causal conclusions, although longitudinal research help an affiliation between weight problems and polypharmacy. Nevertheless, given the research’s findings, researchers consider that focused methods to deal with weight problems may probably scale back polypharmacy and enhance well being outcomes in older adults.
Weight problems could also be a modifiable driver of polypharmacy
General, the findings counsel that weight problems, significantly belly weight problems measured by waist circumference, is related to a considerably increased probability of polypharmacy in older adults. Relying on how weight problems was outlined, it accounted for an estimated one in seven to 1 in 4 polypharmacy circumstances, highlighting weight problems as a probably modifiable contributor to medicine burden, though the cross-sectional research can not set up trigger and impact.
Addressing weight problems might scale back medicine burden, however weight reduction medicines must be thought of fastidiously, given their potential to each alleviate and add to polypharmacy via a right away enhance in medicine burden and unintended effects. Evaluating the impression of weight problems therapies on total medicine use warrants additional research.
Obtain your PDF copy by clicking right here.
